Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.500 | None | 0.975 | 128 | 0 | 1987 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.500 | None | 0.976 | 120 | 0 | 1976 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.500 | None | 0.978 | 111 | 0 | 1988 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.984 | 66 | 0 | 1982 | 2020 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
group | 0.500 | None | 0.987 | 65 | 0 | 1995 | 2019 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.500 | None | 0.964 | 40 | 0 | 2002 | 2017 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.987 | 35 | 0 | 1996 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.400 | None | 0.988 | 33 | 0 | 1990 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 33 | 0 | 2001 | 2018 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.400 | None | 0.979 | 29 | 0 | 1999 | 2018 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
group | 0.400 | None | 1.000 | 27 | 0 | 1993 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.500 | None | 0.974 | 27 | 0 | 1996 | 2018 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
group | 0.400 | None | 0.981 | 25 | 0 | 1991 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 1.000 | 23 | 0 | 1992 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.400 | None | 1.000 | 21 | 0 | 1990 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.400 | None | 0.967 | 20 | 0 | 2001 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.400 | None | 1.000 | 18 | 0 | 2002 | 2020 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 1996 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 0.978 | 18 | 0 | 1998 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 17 | 0 | 2000 | 2009 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
group | 0.400 | None | 1.000 | 16 | 0 | 2003 | 2018 | ||||||||
|
secretoglobin family 2A member 2 | 0.722 | 0.308 | 1.7E-04 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2002 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.400 | None | 1.000 | 15 | 0 | 2002 | 2019 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 2003 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.400 | None | 1.000 | 14 | 0 | 2002 | 2016 |